Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations

被引:104
作者
Gourh, Pravitt [1 ]
Agarwal, Sandeep K. [1 ]
Martin, Ezequiel [2 ]
Divecha, Dipal [1 ]
Rueda, Blanca [2 ]
Bunting, Haley [1 ]
Assassi, Shervin [1 ]
Paz, Gene [1 ]
Shete, Sanjay [3 ]
McNearney, Terry [4 ]
Draeger, Hilda [5 ]
Reveille, John D. [1 ]
Radstake, T. R. D. J. [6 ]
Simeon, Carmen P. [7 ]
Rodriguez, Luis [8 ]
Vicente, Esther [9 ]
Gonzalez-Gay, Miguel A. [10 ]
Mayes, Maureen D. [1 ]
Tan, Filemon K. [1 ]
Martin, Javier [2 ]
Arnett, Frank C. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Div Rheumatol & Clin Immunogenet, Dept Internal Med, Houston, TX 77030 USA
[2] CSIC, Inst Parasitol & Biomed, Granada, Spain
[3] Univ Texas MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Dept Epidemiol, Houston, TX 77030 USA
[4] Univ Texas Med Branch Galveston, Galveston, TX USA
[5] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[6] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Nijmegen, Netherlands
[7] Hosp Gen Valle Hebron, Dept Internal Med, Barcelona, Spain
[8] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain
[9] Hosp Princesa, Dept Rheumatol, Madrid, Spain
[10] Hosp Xeral Calde, Dept Rheumatol, Lugo, Spain
关键词
Scleroderma; Systemic sclerosis/SSc; Polymorphism/SNP; BLK; C8orf13; Anti-Topoisomerase I; Anti-centromere; Genetics; Autoantibody; rs13277113; rs2736340; PERIPHERAL-BLOOD CELLS; TYROSINE KINASE GENE; LUPUS-ERYTHEMATOSUS; CHROMOSOMAL LOCALIZATION; MOLECULAR-CLONING; SCLERODERMA; BLK; EXPRESSION; PATHOGENESIS; ACTIVATION;
D O I
10.1016/j.jaut.2009.08.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: Genetic studies in the systemic sclerosis (SSc), an autoimmune disease that clinically manifests with dermal and internal organ fibrosis and small vessel vasculopathy, have identified multiple susceptibility genes including HLA-class 11, PTPN22, IRF5, and STAT4 which have also been associated with other autoimmune diseases, such as systemic lupus erythematosus (SLE). These data suggest that there are common autoimmune disease susceptibility genes. The current report sought to determine if polymorphisms in the C8orf13-BLK region (chromosome 8p23.1-B lymphoid tyrosine kinase), which is associated with SLE, are associated also with SSc. Methods: Two variants in the C8orf13-BLK region (rs13277113 & rs2736340) were tested for association with 1050 SSc cases and 694 controls of North Americans of European descent and replicated in a second series 589 SSc cases and 722 controls from Spain. Results: The "T" allele at rs2736340 variant was associated with SSc in both the U.S. and Spanish case-control series (P = 6.8 x 10(-5), OR 1.27, 95% Cl 1.1-1.4). The "A" allele at rs13277113 variant was associated with SSc in the U.S. series only (P = 3.6 x 10(-4), OR 1.32, 95% Cl 1.1-1.6) and was significant in the combined analyses of the two series (P = 2.0 x 10(-3); OR 1.20, 95% Cl 1.1-1.3). Both variants demonstrated an association with the anti-centromere antibody (P = 2.2 x 10(-6) and P = 5.5 x 10(-4), respectively) and limited SSc (P = 3.3 x 10(-5) and P = 2.9 x 10(-3), respectively) in the combined analysis. Peripheral blood gene expression profiles suggest that B-cell receptor and NF kappa B signaling are dysregulated based on the risk haplotype of these variants. Conclusion: We identify and replicate the association of the C8orf13-BLK region as a novel susceptibility factor for SSc, placing it in the category of common autoimmune disease susceptibility genes. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 38 条
  • [1] Genetics and genomic studies in scleroderma (systemic sclerosis)
    Agarwal, Sandeep K.
    Tan, Filernon K.
    Arnett, Frank C.
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2008, 34 (01) : 17 - +
  • [2] An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis
    Alkassab, F.
    Gourh, P.
    Tan, F. K.
    McNearney, T.
    Fischbach, M.
    Ahn, C.
    Arnett, F. C.
    Mayes, M. D.
    [J]. RHEUMATOLOGY, 2007, 46 (08) : 1248 - 1251
  • [3] Autoantibodies to fibrillarin in systemic sclerosis (scleroderma) - An immunogenetic, serologic, and clinical analysis
    Arnett, FC
    Reveille, JD
    Goldstein, R
    Pollard, KM
    Leaird, K
    Smith, EA
    Leroy, EC
    Fritzler, MJ
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (07): : 1151 - 1160
  • [4] Is scleroderma an autoantibody mediated disease?
    Arnett, Frank C.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (06) : 579 - 581
  • [5] Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
    Baechler, EC
    Batliwalla, FM
    Karypis, G
    Gaffney, PM
    Ortmann, WA
    Espe, KJ
    Shark, KB
    Grande, WJ
    Hughes, KM
    Kapur, V
    Gregersen, PK
    Behrens, TW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) : 2610 - 2615
  • [6] The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
    Cancro, Michael P.
    D'Cruz, David P.
    Khamashta, Munther A.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (05) : 1066 - 1073
  • [8] DOUVAS AS, 1979, J BIOL CHEM, V254, P10514
  • [9] DREBIN JA, 1995, ONCOGENE, V10, P477
  • [10] DYMECKI SM, 1992, J BIOL CHEM, V267, P4815